Author： Agwale S.M. Zeh C. Robbins K.E. Odama L. Saekhou A. Edubio A. Njoku M. Sani-Gwarzo N. Gboun M.S. Gao F. Reitz M. Hone D. Pieniazek D. Wambebe C. Kalish M.L.
Publisher： Elsevier
ISSN： 0264-410X
Source： Vaccine, Vol.20, Iss.16, 2002-05, pp. : 2131-2139
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Gilbert P.B. Chiu Y.-L. Allen M. Lawrence D.N. Chapdu C. Israel H. Holman D. Keefer M.C. Wolff M. Frey S.E. NIAID HIV Vaccine Trials Network
Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. :
Access to resources
Recommend
Some important issues in the planning of phase III HIV vaccine efficacy trials
By Boily M.-C. Masse B.R. Desai K. Alary M. Anderson R.M.
Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. :
Past, present and future of HIV vaccine trials in developing countries
By Esparza J. Osmanov S. Pattou-Markovic C. Toure C. Chang M.-L. Nixon S.
Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. :
Development of a multicomponent candidate vaccine for HIV-1
By Kim J.J. Ayyavoo V. Bagarazzi M.L. Chattergoon M. Boyer J.D. Bin W. Weiner D.B.
Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. :